Bruce Carlson

Business Insights
Romanian IVD market worth watching, rose to $464M in 2022
The Eastern European country's IVD market will grow 25% faster than that of the United States, according to Kalorama Information in its latest 30-Country IVD Market Atlas.
May 31, 2023
Business Financial Results Social
Business Insights
U.K. IVD market grows to $4.6 billion; Brexit not a factor
The U.K. market is expected to grow just under 3% per year for the next five years, the report said, faster than Italy, France, or the Netherlands, and at about the same rate as Germany.
May 4, 2023
Business Deal Corporate Social
Business Insights
Declining COVID-19 test market may still reach $25M in 2023: Report
Despite a decline in sales, COVID-19 is expected to represent one of the larger single-disease categories in IVD testing, according to Kalorama. Rapid testing, mostly antigen-based, will hold up the market while growth drops in lab-based PCR testing.
April 28, 2023
Coronavirus Business Graphic3 Social
Business Insights
Point-of-care IVD sales rose to $45 billion in 2022
Numerous trends will combine to enable a growing market. According to the Kalorama report, growth of 3.3% per year is expected over the forecast period from 2022 to 2027.
April 19, 2023
3d Closeup Coronavirus Social
Business Insights
Brazilian IVD market rises to $1.7B
The demand for clinical testing equipment in Brazil is partly driven by an aging population, Kalorama noted. People 65 and over are expected to account for 14.1% of the total population by 2032.
April 18, 2023
Financials Growth Revenue Business Social
Business Insights
Swedish IVD market estimated at $804 million in 2022: Kalorama Information
Critical care point-of-care tests, used for assessment of emergency room (ER) and intensive care unit (ICU) patients in hospitals or ambulatory settings, are expected to grow about three times faster in Sweden than in the U.S. over the next five years.
March 31, 2023
Business Financial Results Social
Business Insights
U.S. IVD market reaches $53 billion
According to Kalorama Information, the U.S. IVD market is projected to grow at a 2.4% average annual rate through 2027.
March 22, 2023
Business Intelligence Social
Business Insights
IVD physician office market was $8.3 billion in 2022: Kalorama
An increase in the number of diseases for which physician offices are often the first to test is influencing physician office lab IVD revenue growth.
January 23, 2023
Business Intelligence 400
Liquid Biopsy
$1.3 billion liquid biopsy market represents the present and future of clinical oncology: Kalorama
The liquid biopsy market can be segmented by the type of analyte detected and analyzed. There are four main categories: circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes and other analytes, and multiple analytes.
January 19, 2023
Lab Test Tube Dna Blood Social
Business Insights
Highly competitive molecular diagnostics market reaches $21B: Kalorama
The market largely consists of COVID-19 sales, but future growth in the market will be fueled by other applications, according to Kalorama Information.
November 8, 2022
Business Financial Results Social
Page 1 of 7
Next Page
Top Stories
Test Tube Liquid Sample Social
Agreement
BioMérieux subsidiary secures DoD contract for infectious disease testing system
BioFire Defense, a subsidiary of BioMérieux, has secured an order-dependent contract with the U.S. Department of Defense (DoD) to provide support for a military-use version of its multiplex polymerase chain reaction infectious disease test system.
Cigarette Smoking Social
Schizophrenia
Genetic predisposition to smoking may drive schizophrenia heart disease risk: Study
Artificial Intelligence Drug Design Funding Social
Financing
Harbinger Health raises $140M in series B funding
Plasmodium Falciparum Malaria Cdc Social
Malaria
Study shows malaria drug resistance occurring in Horn of Africa
Latest in at-home or lab-based STI testing
Sponsor Content
Latest in at-home or lab-based STI testing
More in Home
BioMérieux subsidiary secures DoD contract for infectious disease testing system
BioFire Defense, a subsidiary of BioMérieux, has secured an order-dependent contract with the U.S. Department of Defense (DoD) to provide support for a military-use version of its multiplex polymerase chain reaction infectious disease test system.
September 29, 2023
Test Tube Liquid Sample Social
Genetic predisposition to smoking may drive schizophrenia heart disease risk: Study
Genetic factors are unlikely to directly drive the increased rate of cardiovascular disease in schizophrenia patients but may influence lifestyle, according to a paper in the American Journal of Psychiatry.
September 29, 2023
Cigarette Smoking Social
Harbinger Health raises $140M in series B funding
Biotech company Harbinger Health has raised $140 million in a series B funding round.
September 29, 2023
Artificial Intelligence Drug Design Funding Social
Study shows malaria drug resistance occurring in Horn of Africa
Malaria parasites in eastern Africa have developed resistance to artemisinins, essential first-line drugs used in combination therapies, jeopardizing the progress made in recent decades against the disease.
September 29, 2023
Plasmodium Falciparum Malaria Cdc Social
Day Zero Diagnostics to use $16M in funding to improve management of antibiotic-resistant infections
Day Zero Diagnostics recently raised $16 million to fund the application of whole-genome sequencing and artificial intelligence to antibiotic-resistant infections, facilitating the firm’s goal of changing how infectious diseases are diagnosed.
September 28, 2023
Dna Sequencing2
U.S. Attorney’s Office wins $370M judgment in Medicare fraud case
The U.S. Attorney's Office for the Middle District of Florida won a $370 million default judgment against a Kentucky lab owner and his businesses for a lab testing scheme intended to defraud Medicare.
September 28, 2023
Gavel Money Social
Ginkgo Bioworks, Pfizer collaborate on RNA-based therapeutics
Cell engineering company Ginkgo Bioworks has entered into an agreement with Pfizer to discover and develop RNA-based drug candidates.
September 28, 2023
Rna Strand Social
Study launched on early intervention with immune modulators in COVID-19
A clinical trial has been launched to determine if there are benefits to early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness.
September 26, 2023
Coronavirus Covid Blue Social
U.S. government investing $600M in COVID-19 test manufacturing
The U.S. Department of Health and Human Services announced that it is investing $600 million in funding into COVID-19 test manufacturing.
September 26, 2023
Dollar Money Coronavirus Mask Social
Some emergency sepsis screening tools inadequate, EU study suggests
Two out of the four internationally recommended screening tools used by emergency medical services are inadequate for recognizing sepsis, say German researchers.
September 26, 2023
Sepsis Bacteria Social
Thermo Fisher Scientific prepared to expand its work at manufacturing facility
Thermo Fisher Scientific executives voiced hopes for expanding work to help combat diseases at its giant $180 million viral vector manufacturing site in Plainville, MA.
September 27, 2023
Manufacturing Facility Process Social
HIV vaccine trial begins enrollment in U.S., South Africa
A clinical trial for a preventive HIV vaccine has begun enrollment in both the U.S. and South Africa.
September 25, 2023
Vial Vaccine Vial Tech Social
Page 1 of 92
Next Page